...
首页> 外文期刊>Turkish journal of chemistry >Molecular modeling and antimycobacterial studies of Mannich bases: 5-hydroxy-2-methyl-4H-pyran-4-ones
【24h】

Molecular modeling and antimycobacterial studies of Mannich bases: 5-hydroxy-2-methyl-4H-pyran-4-ones

机译:曼尼希碱基的分子建模和抗分枝杆菌研究:5-羟基-2-甲基-4H-吡喃-4-酮

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The World Health Organization lists tuberculosis among the top 3 leading causes of death from a single infectious agent, and reported cases of multidrug-resistant tuberculosis (MDR-TB) are on the rise.In an attempt to improve MDR-TB drug-directed therapy, we synthesized 11 4-substituted piper-azine derivatives of 3-hydroxy-6-methyl-4H-pyran-4-one pharmacophore by reacting 5-hydroxy-2-methyl-4H-pyran-4-one with suitable piperazine derivatives under Mannich reaction conditions. Inhibitory effects of the 11 compounds on Escherichia coli DNA gyrase were evaluated via DNA gyrase supercoiling assay. The minimum inhibitory concentrations (MIC) of the 11 compounds and 41 compounds from our previous studies against Mycobacterium tuberculosis H37RV were assessed, in vitro, by a broth dilution method. To determine the interaction pattern between active site amino acids and all 52 compounds, homology modeling for the construction of M. tuberculosis DNA gyrase B subunit was performed, followed by a docking study.The data presented here could prove useful in future studies on interaction field analysis and high throughput virtual screening of the derivatives of the 3-hydroxy-6-methyl-4 H -pyran-4-one pharmacophore toward the development of more clinically applicable compounds.
机译:世界卫生组织将结核病列为由单一传染病导致的三大主要死亡原因,并且报告的耐多药结核病(MDR-TB)呈上升趋势,以改善MDR-TB药物导向治疗,我们通过在合适的条件下,使5-羟基-2-甲基-4H-吡喃-4-酮与合适的哌嗪衍生物反应,合成了11种3-羟基-6-甲基-4H-吡喃-4-酮药的4-取代的哌嗪衍生物。曼尼希反应条件。通过DNA回旋酶超螺旋测定法评估了11种化合物对大肠杆菌DNA回旋酶的抑制作用。通过肉汤稀释法在体外评估了我们先前对结核分枝杆菌H37RV的研究中11种化合物和41种化合物的最低抑菌浓度(MIC)。为了确定活性位点氨基酸与所有52种化合物之间的相互作用模式,进行了结核分枝杆菌DNA促旋酶B亚基构建的同源性建模,然后进行了对接研究。本文提供的数据可能被证明对将来在相互作用领域的研究有用分析和对3-羟基-6-甲基-4 H-吡喃-4-酮药效基团的衍生物进行高通量虚拟筛选,以开发更具临床应用价值的化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号